Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...
Organoids are three-dimensional miniature models of organs, grown in a dish. They have become a valuable tool for studying ...
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...
As the landscape of cancer treatment evolves, fusion genes stand at the forefront of precision medicine, offering new hope for patients. With continuous advancements in genomic research and targeted ...
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...
Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...
Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...
Cancer drug in development at Ohio State could treat some of the most difficult forms of the illness
This weekend, thousands of riders will take to the streets for Pelotonia — the annual bike ride that raises millions of dollars for cancer research right here in Columbus. One of the projects ...
Ibuprofen’s anti-inflammatory action may influence cancer risk, but evidence remains complex and routine use for prevention is not advised. Ibuprofen is one of the most widely used pain relievers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results